Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03263130 · ClinicalTrials.gov registry record
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
A clinical trial of Emphysema and COPD, Emphysema, Asthma COPD Overlap, sponsored by Gelb, Arthur F., M.D..
- Recruiting
- Registry status
- 60
- Enrollment target
- 2
- Study locations
NCT03263130: Recruiting study of Emphysema and COPD, Emphysema, Asthma COPD Overlap, sponsored by Gelb, Arthur F., M.D..
NCT03263130 is a study of Emphysema and COPD, Emphysema, Asthma COPD Overlap that is actively recruiting participants, run by Gelb, Arthur F., M.D.. The registered enrollment target is 60 participants, below the 3,801-participant average among 25 other Emphysema trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03263130, a study of Emphysema and COPD, Emphysema, Asthma COPD Overlap, is actively recruiting participants, sponsored by Gelb, Arthur F., M.D..
- RECRUITING
- Registry status
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (\>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatment may include short and long acting inhaled beta2agonists, short and long acting inhaled muscarinic receptor antagonists, inhaled and or oral corticosteroid, oral antibiotic, supplemental oxygen, and PDE type 4 inhibitor. In some cases, the patient may have had a history of asthma preceding the development of COPD (Asthma COPD Overlap).
Primary Outcome
Contribution of loss of lung lastic recoil vs intrinsic airway obstruction
Conditions Studied
Interventions
- OTHER As above: diagnosis: COPD, Emphysema, Asthma-COPD Overlap
Study Locations (2)
California
- Arthur F Gelb MD - Lakewood
- Arthur F Gelb MD - Lakewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2027-12-01 |
What NCT03263130 shows while recruiting
NCT03263130 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 3,801-participant average among 25 other Emphysema trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Emphysema appearing as the primary indexed condition, and to 1 intervention - of which As above: diagnosis: COPD, Emphysema, Asthma-COPD Overlap is the first listed.
NCT03263130 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03263130 about?
NCT03263130 is a clinical study titled "Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap". The purpose of this cross-sectional, observational study is to evaluate the site and mechanism(s) for expiratory airflow limitation in chronic, treated, current or former smokers (\>15 pack years) with COPD, Emphysema, and Asthma-COPD Overlap with mild to severe expiratory airflow limitation. Treatm...
What is the current status of trial NCT03263130?
This trial is currently recruiting. The enrollment target is 60 participants. The study started on 2017-01-01. Estimated completion is 2027-12-01.
What conditions does trial NCT03263130 study?
This clinical trial studies the following conditions: Emphysema, COPD, Emphysema, Asthma COPD Overlap.
What interventions are being tested in trial NCT03263130?
The interventions under investigation include: As above: diagnosis: COPD, Emphysema, Asthma-COPD Overlap (OTHER).
Who is sponsoring clinical trial NCT03263130?
This trial is sponsored by Gelb, Arthur F., M.D., which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03263130 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emphysema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03263130's enrollment target sits among peer trials
60 18th of 25 higher than 8 of 25 other Emphysema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Emphysema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COPD Patient-Powered Research Network
RECRUITING
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
RECRUITING · Phase 2
-
Biological Effects of Quercetin in COPD Phase II
RECRUITING · Phase 2
-
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
RECRUITING · NA
-
Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
RECRUITING · NA
-
STRIVE Post-Market Registry Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI